FLOSEAL
Report
- Report Number
- 1416980-2024-01240
- Event Type
- Injury
- Date Received
- March 20, 2024
- Report Date
- July 9, 2024
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Product Code
- LMF
- PMA / PMN Number
- NI
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- TU
- Reporter Occupation
- PHYSICIAN
- Health Professional
- Yes
Narratives
C1: MANUFACTURER/COMPOUNDER: BAXTER HEALTHCARE - VIENNA INDUSTRIESTRASSE 67 VIENNA 1220 AUSTRIA. E1: (B)(6). G1: DEVICE MANUFACTURER POSTAL CODE: (B)(4). AYDOGAN, TAHSIN BATUHAN, BINBAY, MURAT (2023). CAN A SINGLE-LAYER OF RENORRHAPHY BE APPLIED WITH HEMOSTATIC AGENT IN ROBOT ASSISTED LAPAROSCOPIC NEPHRON-SPARING SURGERY APPLIED TO COMPLEX RENAL TUMORS? YENI ÜROLOJI DERGISI - THE NEW JOURNAL OF UROLOGY, 18(1):55-61. DOI: 10.33719/YUD.2023;18-1-1191867. H10: THE DEVICE WAS NOT RETURNED AND THE LOT NUMBER IS UNKNOWN; THEREFORE, A DEVICE ANALYSIS COULD NOT BE COMPLETED. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
CORRECTED INFORMATION: G2 AND G4. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.
ONE PATIENT UNDERWENT A ROBOTIC PARTIAL NEPHRECTOMY DUE TO A COMPLEX RENAL TUMOR WHEREIN FLOSEAL WAS APPLIED. AFTER AN UNSPECIFIED AMOUNT OF TIME THE PATIENT PRESENTED WITH A FEVER (NOT FURTHER SPECIFIED). UNSPECIFIED ANTIPYRETICS WERE INITIATED. PATIENT OUTCOME WAS NOT PROVIDED. NO FURTHER INFORMATION WAS AVAILABLE AT THE TIME OF THIS REPORT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 523839 | FLOSEAL | AGENT, ABSORBABLE HEMOSTATIC, COLLAGEN BASED | LMF | BAXTER HEALTHCARE CORPORATION | NA | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Required Intervention |